Skip to main content
Loading...
Menu social network
LinkedIn
Facebook
X
Youtube
Menu top
Assistance
User account menu
Log in
Main navigation
Home
Programme
Download the app
App
Download the app
App
Menu
Login
Close
Main navigation mobile
Home
Programme
Menu top
Assistance
Menu social network
LinkedIn
Facebook
X
Youtube
10 results
D3.488 - Early Risk Assessment and Recognition of Allergies in Children: rationale, methodology, and proposed algorithms
D3.489 - Anaphylaxis Diagnosis and Treatment from the Perspective of Primary Care Physicians
D3.490 - AllergyIQ: An Interactive Virtual Educational Platform in Allergy and Immunology
D3.491 - Satisfaction with Sebetralstat as On-Demand Treatment of Hereditary Angioedema Attacks in KONFIDENT-S
D3.492 - Validation of the Portuguese version of the Food Allergy Quality of Life Questionnaire Adult Form (P-FAQLQ-AF)
- D1.532 - Phenotypic and Functional Comparison of LAD2, HMC-1.2, and Primary Human Mast Cells
- D1.529 - Evaluating the Disease-Modifying Potential of Elenestinib, a Highly Potent and Selective Tyrosine Kinase Inhibitor, in Patients With Indolent Systemic Mastocytosis: An Update on the Pivotal HARBOR Study
- D1.530 - Patient Experience of Most Burdensome Nonadvanced Systemic Mastocytosis Symptoms From the Pivotal Summit Trial of Bezuclastinib
- D1.531 - Avapritinib in Indolent Systemic Mastocytosis: Real-world Data from a Greek Case Series
- D1.533 - Systemic mastocytosis despite normal baseline tryptase: a diagnostic pitfall in recurrent life-threatening anaphylaxis
Download the app
The congress at your fingertips
Available on
Download